Search News Archives
Follow us on
Conferences | Events
Media Partners
New England Biolabs

New England Biolabs

New England Biolabs

Products

Contact New England Biolabs


If you have not logged into the website then please enter your details below.

All articles from New England Biolabs

  Avacta Agrees Affimer Reagent Licensing Deal with New England Biolab

avactaAvacta Group plc (AIM: AVCT), the developer of Affimer® biotherapeutics and reagents, is pleased to announce that it has agreed a commercial license with New England Biolabs® (NEB®) (Ipswich MA, USA), a global leader in the discovery and production of enzymes for molecular biology applications, to commercialise a product using the Affimer technology for use in both life science research and diagnostics assays. Avacta and NEB have been collaborating to develop Affimers to combine with NEB’s reagents....

 

  New England Biolabs and TTP plc Collaborate to Provide Services for Molecular Diagnostics

New offering will include integrated and comprehensive product development services for fast tracking innovation, progressing ideas into commercial products

ttp labtechTTP plc, a leading technology and product development company, and New England Biolabs, Inc. (NEB®), an industry leader in the discovery and production of enzymes for molecular biology applications, announce that they have established a non-exclusive partnership...

 

  NEBNext Delivers an Improved qPCR-Based Library Quantitation Solution

Several innovations yield unmatched reproducibility and consistency of NGSlibraries 

New England BiolabsNew England Biolabs® (NEB®) announces the release of the NEBNext Library Quant Kit for Illumina®, a qPCR-based solution for accurate next generation sequencing library quantitation. This kit offers several improvements over other commercially available library quantitation methods, including greater accuracy and, consequently, higher correlation with cluster numbers, higher reproducibility, a more convenient protocol and supplied kit components...

 

  Population Genetics assigns NGS patent to NEB

Population Genetics Assigns Asymmetric Adaptor Library Construction Patent To New England Biolabs

NebNext Ultra

Population Genetics Technologies Ltd (PGT) and New England Biolabs, Inc. (NEB) announce that PGT has assigned exclusive rights to a patent (US 8,420,319) covering methods for asymmetric adaptor library construction to NEB. As part of next generation sequencing (NGS) library preparation, this technology enables increased efficiency at the adaptor ligation step, resulting in high yield libraries and minimized adaptor-dimer formation. In conjunction with NEB’s other innovations in NGS library preparation, this patent further strengthens the NEBNext® product portfolio...

 

  New England Biolabs Reports Significant Process Improvements Using IDT’s gBlocks

Providing fast and accurate gene assembly

decodedThe latest issue of Integrated DNA Technologies' (IDT's) DECODED newsletter highlights how New England Biolabs (NEB) researchers were able to expe­dite the cloning of a 2.1 kb gene into a linearized pET21-a bacterial expression vector using 5 gBlocksTM Gene Fragments that spanned the entire 2.1 kb sequence. Cloning, sequencing, and characteriza­tion of protein activity took less than 4 days, shorter than necessary for a third party to synthesize the complete gene and provide a finished construct.

 

 

Media Partners